Shares Investor Evening (London)

Shares Investor Evening (London)

Wednesday 27 November 2019

Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies.

The event on Wednesday 27 November 2019 in London will include:

• An opportunity for you to talk directly with the directors and ask your questions about the companies’ core strengths and their short and long-term business strategy

• Meet fellow investors and share your investing experience

• Complimentary drinks and snacks

More about the companies presenting:

Amryt Pharma (AMYT) is a revenue-generating orphan drug company focused on acquiring, developing and commercialising products that help improve the lives of patients.

Rockfire Resources (ROCK) the gold and base-metal focused explorer, announces that it has recently completed reprocessing of historical geophysical data from its 100%-owned Plateau Gold Deposit in Queensland, Australia.

Shanta Gold (SHG) is a gold producing company. The group's principal activities are the gold investment in mining, exploration, and production in Tanzania. Its main project operations are New luika gold mine, Singida and Songea.

Silence Therapeutics (SLN) is a biotechnology company in the United Kingdom. It uses its RNA technology to develop drugs to address genetic disorders.

SkinBio Therapeutics (SBTX) is a life science company. The company is engaged in the development of technology to protect, manage and restore skin utilising proteins found in human microbiota.

 

Who Should Attend

The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors. 

Evening timings

18.00
Registration and coffee
18.30
Presentations
Kieran Rooney, Vice President - Amryt Pharma (AMYT)
David Price, CEO - Rockfire Resources (ROCK)
Eric Zurrin, CEO - Shanta Gold (SHG)
Dr. Rob Quinn, Interim CFO - Silence Therapeutics (SLN)
Stuart Ashman, Chief Executive - SkinBioTherapeutics (SBTX)
20.00
Drinks reception and canap├ęs
21.00
Close

Venue

Novotel Tower Bridge, London EC3N 2NR

Sponsored by

Featured Companies